fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Pfizer Ltd

Pfizer Ltd

Updated on November 9, 2019

Stock/Share Code - PFIZER

Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products.(Source : 201903 Annual Report Page No: 131)

Below is the details of PFIZER Pfizer Ltd

Market Cap₹13,383 Cr.
Current Price ₹4,003.15 as on 13 Nov 19
52 Week High / Low Price₹3,789.95 / ₹2,490
Face Value₹10
Stock P/E29.74
Book Value₹658.25
Dividend Yield0.77 %
ROCE23.22 %
ROE15.07 %
Sales Growth (3yrs)1.13 %
SectorPharmaceuticals
IndustryPharmaceuticals - Multinational
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 25.52%
Cons: Company has a low return on equity of 13.56% for last 3 years.

Pfizer Ltd Price Chart

Pfizer Ltd Price Chart

Pfizer Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Glaxosmi. Pharma ₹14.75 48.35 ₹20,586.22 Cr. 1.65 ₹113.54 Cr. 27.17 7.11 787.97 31.11
2. Abbott India ₹11,794.6 40.10 ₹19,440.78 Cr. 0.71 ₹116.94 Cr. 41.92 18.22 998.89 37.36
3. Sanofi India ₹6,539.55 36.36 ₹14,138.35 Cr. 1.37 ₹97.4 Cr. -2.21 9.41 747.90 28.84
4. Pfizer 29.74 ₹13,382.81 Cr. 0.77 ₹112.81 Cr. 22.83 6.26 544.40 23.22
5. Proc. Gam. Heal. ₹133.8 8.01 ₹6,830.07 Cr. 10.69 ₹44.08 Cr. -8.76 6.06 233.63 78.16
6. Astrazeneca Phar ₹2,541.4 67.59 ₹4,701.63 Cr. 0.00 ₹21.52 Cr. 236.78 26.71 204.56 26.51
7. Novartis India ₹65.5 62.57 ₹1,401.57 Cr. 1.76 ₹0.79 Cr. -92.10 -20.85 109.31 7.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Pfizer Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Sales536491438421571457520512520514536544
YOY Sales Growth %4.79%-2.81%-14.52%-16.02%6.63%-7.09%18.69%21.71%-8.99%12.54%3.02%6.26%
Expenses444429343344404339381382390359385378
Material Cost %43.91%41.46%36.88%33.92%41.92%35.79%37.33%36%39.04%34.41%34.31%35.09%
Employee Cost %15.08%17.82%13.67%19.19%13.89%14.37%17.04%15.74%15.01%16.29%15.21%16.1%
Operating Profit91629577167118138130130154151166
OPM %17%13%22%18%29%26%27%25%25%30%28%31%
Other Income1284629272432313137643536
Interest000000-000012
Depreciation161516151618171818181825
Profit before tax2039210789175132153142149201168175
Tax %38%32%36%35%36%34%31%35%36%34%35%36%
Net Profit126626857111871059296132109113
EPS in Rs27.6113.6314.8712.5024.2919.0722.8420.0720.9428.8423.9324.66
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales6726747721,2521,0931,0491,1121,8532,0121,9661,9692,0822,114
Sales Growth %1.81%0.36%14.57%62.18%-12.71%-4.07%5.99%66.66%8.63%-2.29%0.11%5.74%%
Expenses5555496449838978658721,4381,5791,6161,4681,5161,512
Material Cost %34.46%35.25%37.26%31.18%32.85%31.76%33.72%39.94%39.11%40.51%37.58%35.93%%
Manufacturing Cost %4.73%4.84%6.28%6%5.92%6.07%5.67%4.43%3.76%3.92%3.5%3.55%%
Employee Cost %14.7%15.05%17.68%18.37%17.67%20.13%17.25%12.76%13.78%15.46%15.97%15.56%%
Other Cost %34.39%31.17%22.22%22.93%25.57%24.48%21.83%20.52%21.83%22.31%17.52%17.78%%
Operating Profit117125128270197184239414433350501566601
OPM %17%19%17%22%18%18%22%22%22%18%25%27%28%
Other Income3433049089925191094497232114167173
Interest0002221212123
Depreciation101181210882505863667178
Profit before tax450419210345278694340207470517548660693
Tax %25%29%35%34%33%27%35%66%35%35%34%35%
Net Profit33929913722618550322170305337360429450
EPS in Rs108.9198.1243.7554.8859.84163.0912.8312.7266.6673.6178.7093.7898.37
Dividend Payout %24%12%27%22%20%19%486%82%22%27%25%24%

Compounded Sales Growth

  • 10 Years:: 11.94%
  • 5 Years:: 13.37%
  • 3 Years:: 1.13%
  • TTM:: 2.61%

Compounded Profit Growth

  • 10 Years:: 10.87%
  • 5 Years:: 14.32%
  • 3 Years:: 12.77%
  • TTM:: 14.00%

Return on Equity

  • 10 Years:: 14.25%
  • 5 Years:: 13.02%
  • 3 Years:: 13.56%
  • Last Year:: 15.07%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital303030303030304646464646
Equity Capital29.8429.8429.8429.8429.8429.8429.8445.7545.7545.7545.7545.75
Reserves6198709641,1341,2751,6656291,9272,1182,3732,6372,966
Borrowings000000022222
Other Liabilities2222002132252783653186488119281,0811,001
Trade Payables92.11107.27116.2598.71136.34150.9160.19338.99341.12389.56496.23437.86
Total Liabilities8711,0991,2071,3881,5832,0609772,6232,9773,3503,7664,015
Fixed Assets60519236312620944925902950886
Gross Block141.61139.9187.81117.7118115.71114.831288.6980.631021.161132.751138.16
Accumulated Depreciation81.4589.1495.3281.8186.5290.1494.81344.2655.77118.97182.43251.97
CWIP1032120031331510
Investments000494846444337000
Other Assets8001,0161,1131,3021,5031,9889091,6242,0132,4322,8153,129
Inventories95.06124.68113.37159.32183.24165.15151.5387.9360.68321.9297.06386.66
Trade receivables61.3759.7364.39100.17141.78142.09173.39160.02142.3110.32154.8171.66
Cash Equivalents479.79543.06527.41578.46866.261432.94307.79609.291024.651523.091771.861914.34
Loans n Advances161.02288.12408.28370.84177.55104.0987.47171.72193.97184.58269.37319.16
Other Assets etc2.930092.72134.31143.3188.86294.97290.94292.11321.88337.13
Total Assets8711,0991,2071,3881,5832,0609772,6232,9773,3503,7664,015

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Nov 2007Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity17237758024-1613211334532933298
Profit from operations169.26160.72175.92282.42208.5195.15251.77298.9450.89362.9514.93580.44
Working Capital Changes-32.39-7.5312.99-50.26-61.85-2.94.62-40.4268.61148.9110.48-245.07
Taxes paid-112.97-126.73-103.32-148.99-121.81-208.26-123.94-145.01-174.03-182.99-193.61-237.56
Cash from Investing Activity232-79-475727862610368-701-250-23835
Fixed Assets Purchased-13.67-26.67-18.71-7-3.32-0.66-4.22-20.57-43.67-25.29-102.69-4.49
Fixed Assets Sold279.671.730.60.550.26424.342.040.3596.6290.7833.3431.36
Investments purchased-67-107.5-91000000000
Cash from Financing Activity-76-95-43-86-14-43-1,360-1-62-83-110-110
Interest Paid-0.0200000000000
Dividends Paid-75.88-95.2-43.32-86.27-14.13-20.66-1161.11-1.38-50.24-68.62-91.73-91.05
Net Cash Flow17363-1651288567-1,125181-417-3-1723

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Nov 2007Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %37%27%23%32%23%19%29%24%22%17%21%23%
Debtor Days333230294749573226202930
Inventory Turnover6.946.146.499.196.386.027.026.875.385.766.366.09

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Pfizer Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.